[1]
“PHARMACOKINETIC VARIABILITY AND THERAPEUTIC DRUG MONITORING OF SYSTEMIC ANTIFUNGAL AGENTS: MITIGATING HEPATOTOXICITY AND OPTIMIZING EFFICACY IN CRITICALLY ILL COHORTS”, Wor.Bul.Pub.Helt., vol. 56, pp. 85–88, Mar. 2026, Accessed: Sep. 13, 2026. Available: https://scholarexpress.net/index.php/wbph/article/view/5984